![Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL](http://www.pillole.org/public/aspnuke/downloads/immagini/medalmainresults.jpg)
Pillole.org - Pillole: Etoricoxib e diclofenac presentano lo stesso rischio trombotico: studio MEDAL
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673606696669-gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect
![Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/63c765d9-c539-4d2f-8fde-eb1a58bf13e8/joim13505-gra-0001-m.jpg)
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
![PDF) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison PDF) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison](https://i1.rgstatic.net/publication/6685266_Cardiovascular_outcomes_with_etoricoxib_and_diclofenac_in_patients_with_osteoarthritis_and_rheumatoid_arthritis_in_the_Multinational_Etoricoxib_and_Diclofenac_Arthritis_Long-term_MEDAL_programme_a_ran/links/5a1bdf7c4585155c26ae09a8/largepreview.png)
PDF) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673606696669-gr2.jpg)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect
![Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram](https://www.researchgate.net/publication/51841156/figure/fig1/AS:667191997378569@1536082376663/Effect-of-administration-of-ketorolac-etoricoxib-or-diclofenac-in-the-pain-of-ankle.png)